http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2167664-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b8461be492829469685ac6da687e2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0ad073a3abf25b5f8bbfba0e1508031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50
filingDate 1998-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85574624556b2ad023cba4e0fc93ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56add992e0b218b31a3fb4a712eba848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a7a5ea8c5aa61c9618f06b5360ae93
publicationDate 2001-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2167664-C2
titleOfInvention Anti-inflammatory and immunomodulating agent
abstract FIELD: medicine. SUBSTANCE: anti-inflammatory and immunomodulating agent has a homogenate fraction of cut-off placental villi dissolved in 0.95% sodium chloride solution. Invention can be used for treatment of patients with autoimmune diseases, chronic and acute inflammatory diseases associated with noncontrolled activation of respiratory "burst" of neutrophils. Proposed agent shows the purposeful effect providing inhibition of respiratory "burst". EFFECT: enhanced effectiveness of agent. 4 ex
priorityDate 1998-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 16.